Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Non-Current Debt (2022 - 2023)

Historic Non-Current Debt for Gossamer Bio (GOSS) over the last 2 years, with Q4 2023 value amounting to $814000.0.

  • Gossamer Bio's Non-Current Debt fell 9320.99% to $814000.0 in Q4 2023 from the same period last year, while for Dec 2023 it was $814000.0, marking a year-over-year decrease of 9320.99%. This contributed to the annual value of $814000.0 for FY2023, which is 9320.99% down from last year.
  • Per Gossamer Bio's latest filing, its Non-Current Debt stood at $814000.0 for Q4 2023, which was down 9320.99% from $3.6 million recorded in Q3 2023.
  • Gossamer Bio's Non-Current Debt's 5-year high stood at $29.2 million during Q1 2022, with a 5-year trough of $814000.0 in Q4 2023.